NCT00302367View on ClinicalTrials.gov

An Open Label Phase I/II Study of Dopamine Transporter Receptor Occupancy With OROS and Immediate Release Methylphenidate as Measured With C-11 Altropane in Human Subjects

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

April 30, 2004

Study Completion Date

April 30, 2004

Conditions
Healthy Volunteers
Interventions
DRUG

OROS methylphenidate hydrochloride

DRUG

immediate release methylphenidate hydrochloride

Trial Locations (1)

02138

Massachusetts General Hospital, Cambridge

All Listed Sponsors
collaborator

McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

INDUSTRY

lead

Massachusetts General Hospital

OTHER

NCT00302367 - An Open Label Phase I/II Study of Dopamine Transporter Receptor Occupancy With OROS and Immediate Release Methylphenidate as Measured With C-11 Altropane in Human Subjects | Biotech Hunter | Biotech Hunter